BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
101.61
-0.47 (-0.46%)
At close: Aug 31, 2026, 4:00 PM EDT
102.00
+0.39 (0.38%)
Pre-market: Sep 1, 2026, 4:01 AM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $25.52 billion as of August 31, 2026. Its market cap has increased by 6.18% in one year.
Market Cap
25.52B
Enterprise Value
10.50B
1-Year Change
6.18%
Ranking
Category
Stock Price
$101.61
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $25.52B, an increase of 752.25%. That is a compound annual growth rate of 36.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 25.52B | 11.50% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 44.56B |
| BeOne Medicines AG | 41.70B |
| Royalty Pharma | 34.99B |
| Alnylam Pharmaceuticals | 31.73B |
| Insmed | 25.89B |
| Incyte | 25.21B |
| Roivant Sciences | 25.07B |
| Genmab | 19.98B |